Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are the traditional and widely clinically used renoprotective drugs, but they only delay the progression of renal failure other than blocking or reversing renal fibrosis (12). This evidence concerns the gene ACE and Renal insufficiency.